Insider Transactions in Q1 2021 at Applied Therapeutics Inc. (APLT)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 30
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,280
$18.43 P/Share
|
Mar 30
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
Mar 29
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,370
$18.53 P/Share
|
Mar 29
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Mar 26
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.68 P/Share
|
Mar 26
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Mar 15
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.61 P/Share
|
Mar 15
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Mar 12
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.38 P/Share
|
Mar 12
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Mar 11
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,370
$18.48 P/Share
|
Mar 11
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Feb 25
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,295
-100.0%
|
$29,785
$23.2 P/Share
|
Feb 25
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,295
+50.0%
|
$1,295
$1.44 P/Share
|
Feb 24
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,125
-85.88%
|
$51,000
$24.14 P/Share
|
Feb 24
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,125
+50.0%
|
$2,125
$1.44 P/Share
|
Feb 23
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$9,765
$21.84 P/Share
|
Feb 23
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Feb 19
2021
|
Stacy J. Kanter |
BUY
Open market or private purchase
|
Direct |
6,500
+33.33%
|
$143,000
$22.86 P/Share
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
43,478
+1.95%
|
-
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
43,478
-3.38%
|
-
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
43,478
+3.27%
|
$999,994
$23.0 P/Share
|
Feb 03
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,295
-76.83%
|
$33,670
$26.83 P/Share
|
Feb 03
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,295
+50.0%
|
$1,295
$1.44 P/Share
|
Feb 02
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,295
-77.03%
|
$34,965
$27.32 P/Share
|
Feb 02
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,295
+50.0%
|
$1,295
$1.44 P/Share
|
Feb 01
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,460
-60.57%
|
$36,500
$25.4 P/Share
|
Feb 01
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Open market or private sale
|
Direct |
2,325
+77.89%
|
$58,125
$25.47 P/Share
|
Feb 01
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,785
+50.0%
|
$3,785
$1.44 P/Share
|
Jan 21
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$9,300
$20.3 P/Share
|
Jan 21
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Jan 20
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$9,765
$21.08 P/Share
|
Jan 20
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Jan 19
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$9,765
$21.83 P/Share
|
Jan 19
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
Jan 08
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,985
-51.88%
|
$175,670
$22.55 P/Share
|
Jan 08
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,985
+50.0%
|
$7,985
$1.44 P/Share
|
Jan 07
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
765
-100.0%
|
$16,065
$21.88 P/Share
|
Jan 07
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
765
+50.0%
|
$765
$1.44 P/Share
|
Jan 06
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,765
-51.06%
|
$170,830
$22.84 P/Share
|
Jan 06
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,765
+50.0%
|
$7,765
$1.44 P/Share
|